# CPT 96401

> Medicare paid $73.54 for CPT 96401 in the office (non-facility) setting and $73.54 in a facility under the Q4 2023 Physician Fee Schedule, effective October 2023. These are the national allowed amounts before the ~2% sequestration cut and before locality (GPCI) adjustment. This price has been unchanged since Q1 2023, when it decreased 5.5%.

## What it is

Administration of a cancer-fighting drug as a single injection into the fatty tissue just under the skin or into a muscle, rather than through a drip into a vein. Although the injection itself takes moments, the service reflects the surrounding work: verifying the order and dose, handling a hazardous drug safely, assessing the patient before and after, and watching for immediate reactions. This entry is for non-hormonal anti-cancer agents; hormone-type anti-cancer injections and intravenous chemotherapy routes are recorded under separate codes.

## Selected release

- Release: Q4 2023 (2023 D)
- Effective: October 1 – December 31, 2023
- Status indicator: A
- Office (non-facility) national allowed amount: $73.54
- Facility national allowed amount: $73.54
- Sequestration: not applied

## RVUs and formula

- Work RVU: 0.21
- Office (non-facility) practice expense RVU: 1.92
- Facility practice expense RVU: 1.92
- Malpractice RVU: 0.04
- Conversion factor: 33.8872
- Formula: `(work_rvu × work_gpci + pe_rvu × pe_gpci + mp_rvu × mp_gpci) × conversion_factor`

## Source and citation

- Source: Physician relative value file (Q4 2023)
- CMS file: https://www.cms.gov/files/zip/rvu23d.zip
- Parsed file: PPRRVU23_OCT.csv, row 17,822
- Canonical page: https://localishealth.com/cpt/96401/2023/A
- Release-specific citation URL: https://localishealth.com/cpt/96401/2023/D
- Last significant update: 2026-08-04T03:13:13+00:00